| Drug Name |
Methylprednisolone acetate |
| Drug ID |
BADD_D01434 |
| Description |
Methylprednisolone is a [prednisolone] derivative glucocorticoid with higher potency than [prednisone].[A188811] It was first described in the literature in the late 1950s.[A188811,A188814]
Methylprednisolone was granted FDA approval on 24 October 1957.[L10785] In the outbreak of COVID-19, low dose methylprednisolone-based therapy was successful in treating COVID-19-associated pneumonia in one patient with long-term immunosuppression.[A192813] The efficacy of methylprednisolone in novel coronavirus pneumonia is being investigated further in clinical trials.[L12666] |
| Indications and Usage |
Adjunctive therapy for short-term administration in rheumatoid arthritis. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
D07AA01; D10AA02; H02AB04 |
| DrugBank ID |
DB00959
|
| KEGG ID |
D00979
|
| MeSH ID |
D000077555
|
| PubChem ID |
5877
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
50090-0436; 0009-0306; 0009-3475; 38779-0144; 50090-4802; 70518-2894; 50090-0312; 46439-8767; 0009-0274; 60219-1573; 25021-821; 0009-0280; 0009-3073; 50090-0556; 70518-2914; 63187-474; 50090-5894; 16714-089; 0703-0045; 25021-820; 0703-0043; 76420-081; 0703-0063; 70518-2965; 51927-0000; 16714-472; 51552-0958; 70518-2459; 70518-3071; 70121-1552; 50090-1823; 16714-473; 49452-4688; 0703-0051; 70121-1573; 51662-1429; 0009-0026; 76420-260; 0703-0031; 10695-041; 76420-262; 16714-090; 22552-0023; 63275-9942; 68788-8082; 60219-1574; 70121-1574; 70518-2915; 50090-2098; 65089-0016; 16714-088; 82298-117; 52128-148 |
| Synonyms |
Methylprednisolone Acetate | Methylprednisolone-21-acetate | Methylprednisolone 21 acetate | Acetyl-Methylprednisolone | Acetyl Methylprednisolone | Depo-Medrone | Depo Medrone | Depo-Medrol | Depo Medrol | Methylprednisolone Acetate, (11beta,16beta)-isomer | Methylprednisolone Acetate, (11beta,16alpha)-isomer |
